327
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model

, , &
Pages 363-371 | Published online: 15 Feb 2011

References

  • Garcia-GarciaEAndrieuxKGilSCouvreurPColloidal carriers and blood–brain barrier (BBB) translocation: a way to deliver drugs to the brain?Int J Pharm2005298227429215896933
  • IllumLTransport of drugs from the nasal cavity to the central nervous systemEur J Pharm Sci200011111810913748
  • IllumLIs nose-to-brain transport of drugs in man a reality?J Pharm Pharmacol200456131714979996
  • JonesNThe nose and paranasal sinuses physiology and anatomyAdv Drug Deliv Rev2001511–351911516776
  • VinogradovSVBronichTKKabanovAVNanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cellsAdv Drug Deliv Rev200254113514711755709
  • KaurIPBhandariRBhandariSKakkarVPotential of solid lipid nanoparticles in brain targetingJ Control Release200812729710918313785
  • StapletonSLThompsonPAOuCNPlasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primatesCancer Chemother Pharmacol200861464765217541590
  • GibbsJPAdeyeyeMCYangZShenDDValproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transportEpilepsy Res2004581536615066675
  • ScismJLPowersKMArtruAALewisLShenDDProbenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis studyBrain Res20008841–2778611082489
  • BaltesSFedrowitzMTortósCLPotschkaHLöscherWValproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assaysJ Pharmacol Exp Ther2007320133134317043155
  • CornfordEMDiepCPPardridgeWMBlood–brain barrier transport of valproic acidJ Neurochem1985445154115503921665
  • LöscherWCurrent status and future directions in the pharmacotherapy of epilepsyTrends Pharmacol Sci200223311311811879677
  • LöscherWValproate: a reappraisal of its pharmacodynamic properties and mechanisms of actionProg Neurobiol1999581315910321796
  • LöscherWAnimal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsyEpilepsy Res2002501–210512312151122
  • VarshosazJEskandariSTabbakhianMProduction and optimization of valproic acid nanostructured lipid carriers by the Taguchi designPharm Dev Technol2010151899619552542
  • VarshosazJTabbakhianMMohammadiMYFormulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailabilityJ Liposome Res201020428629619958118
  • VenkateswarluVManjunathKPreparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticlesJ Control Release200495362763815023472
  • KishorePRajani KumarVSatyanarayanaVKrishnaDRHPLC determination of valproic acid in human serumPharmazie200358637838012856997
  • EngelJPedleyTAAicardiJEpilepsy: A Comprehensive Textbook2nd edPhiladelphia, PALippincott Williams & Wilkins2007
  • SwinyardEAElectrically induced convulsionsPurpuraDPPenryJKTowerDBExperimental Models of Epilepsy: A Manual for the Laboratory WorkerNew York, NYRaven Press1972434458
  • WohlerASPoklisAA simple, rapid gas-liquid chromatographic procedure for the determination of valproic acid in serumJ Anal Toxicol19972143063099248950
  • ShahdoustiPMohammadiAAlizadehNDetermination of valproic acid in human serum and pharmaceutical preparations by headspace liquid-phase microextraction gas chromatography-flame ionization detection without prior derivatizationJ Chromatogr B Analyt Technol Biomed Life Sci20078501–2128133
  • DillsRLShenDDMethods to reduce background interferences in electron-capture gas chromatographic analysis of valproic acid and its unsaturated metabolites after derivatization with pentafluorobenzyl bromideJ Chromatogr B Biomed Sci Appl19976901–21391529106038
  • BergMVIntranasal Drug Delivery: A Direct Approach to the Cerebrospinal Fluid? [doctoral thesis]. Leiden, The Netherlands: Leiden/Amsterdam Center for Drug Research, Faculty of Mathematics and Natural Sciences, Leiden University;2005
  • AliJAliMBabootaSPotential of nanoparticulate drug delivery systems by intranasal administrationCurr Pharm Des201016141644165320210751
  • MistryAGludSZKjemsJEffect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epitheliumJ Drug Target200917754355219530905
  • KumarMMisraABabbarAKMishraAKMishraPPathakKIntranasal nanoemulsion based brain targeting drug delivery system of risperidoneInt J Pharm20083581–228529118455333
  • ManjunathKVenkateswarluVPharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administrationJ Control Release2005107221522816014318
  • MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm2009379114615719555750
  • BarakatNSOmarSAAhmedAACarbamazepine uptake into rat brain following intra-olfactory transportJ Pharm Pharmacol2006581637216393465
  • WestinUEBoströmEGråsjöJHammarlund-UdenaesMBjörkEDirect nose-to-brain transfer of morphine after nasal administration to ratsPharm Res200623356557216489488
  • VyasTKBabbarAKSharmaRKMisraAIntranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targetingJ Drug Target200513531732416199375
  • VyasTKBabbarAKSharmaRKSinghSMisraAPreliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptanAAPS PharmSciTech200671E816584167
  • VyasTKBabbarAKSharmaRKSinghSMisraAIntranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targetingJ Pharm Sci200695357058016419051
  • ZhangQJiangXJiangWLuWSuLShiZPreparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brainInt J Pharm20042751–2859615081140
  • CostantinoHRIllumLBrandtGJohnsonPHQuaySCIntranasal delivery: physicochemical and therapeutic aspectsInt J Pharm20073371–212417475423
  • BlasiPGiovagnoliSSchoubbenARicciMRossiCSolid lipid nanoparticles for targeted brain drug deliveryAdv Drug Deliv Rev200759645447717570559
  • KakeeATakanagaHHosoyaKSugiyamaYTerasakiTIn vivo evidence for brain-to-blood efflux transport of valproic acid across the blood–brain barrierMicrovasc Res200263223323811866547
  • FrieseASeillerEQuackGLorenzBKreuterJIncrease of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release systemEur J Pharm Biopharm200049210310910704892
  • JadhavKRGambhireMNShaikhIMKadamVJPisalSSNasal drug delivery system-factors affecting and applicationsCurr Drug Ther2007212738